HSBC cuts equities team in Germany as CEO Elhedery continues revamp
The London-headquartered lender is preparing to cut equities sales and trading jobs in the Dusseldorf office, according to sources familiar with the matter. The move is part of chief executive officer Georges Elhedery's effort to revamp the investment bank, the sources said, asking not to be identified discussing private information.
Europe's largest financial institution has already culled dozens of analysts in its investment bank in the last couple of months and it has shut down its US, UK and European equity capital markets and M&A units.
'Equities sales and trading supports the growth of our Prime and Wealth businesses, facilitates equities distribution to the market and supports our global clients investing in equities in both developed markets and emerging markets,' an HSBC spokesperson said in response to questions about the cuts at the German unit.
Since taking over as CEO last September, Elhedery has instituted a widespread overhaul of the bank that has involved creating four new divisions under what he has called his 'simplification' plan. He has also combined HSBC's commercial and investment banking units, while making operations in the UK and Hong Kong standalone businesses. BLOOMBERG
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Times
18 minutes ago
- Business Times
Mondelez beats second-quarter estimates on strong international demand
CADBURY-PARENT Mondelez International beat Wall Street estimates for second-quarter revenue and profit on Tuesday, supported by steady consumer demand for its higher-priced chocolates and biscuits, particularly in international markets including Europe. To offset rising input costs such as cocoa, the Milka and Toblerone chocolate maker has raised prices over successive quarters, boosting profits. Resilient demand despite the hikes supported revenue growth in key segments such as Europe. Volumes in Europe, a major revenue contributor, were down 1.3 percentage points, compared to a 3.1 percentage points dip a year ago, while revenue in the segment surged 18.7 per cent, driven by a 13.8 percentage points rise in pricing. North America volumes declined 2.4 percentage points, widening from a 1.2 percentage points decline in the same quarter last year. Macroeconomic uncertainty from US trade tariffs under President Donald Trump has pressured consumer spending in the United States, pushing budget-conscious shoppers toward cheaper private-label alternatives. Mondelez, which flagged the trend last quarter, said it plans to counter it through value-focused price packs in its American market. BT in your inbox Start and end each day with the latest news stories and analyses delivered straight to your inbox. Sign Up Sign Up 'US consumers are showing more resistance to higher prices compared to consumers in Europe. Looking ahead, having the right pack sizes at the right price points, channels, and locations will be even more critical,' said Arun Sundaram, an analyst with CFRA Research. The company reported net revenue of US$8.98 billion for the quarter ended June 30, topping analysts' average estimate of US$8.84 billion, according to data compiled by LSEG. On an adjusted basis, Mondelez earned 73 cents per share for the quarter, compared with analysts' average estimate of 68 cents per share. Shares of the Chicago-based snack maker fell about 3 per cent in after-hours trading after it maintained its annual forecast despite the quarterly results beat. The company reaffirmed its outlook for 2025 organic net revenue growth of about 5 per cent, but continues to expect adjusted profit to decline 10 per cent. REUTERS
AsiaOne
18 minutes ago
- AsiaOne
No clarity yet on baseline or pharmaceutical tariffs with US: DPM Gan, Singapore News
SINGAPORE – The US government did not negotiate its tariffs on Singapore and did not want to commit on whether the 10 per cent baseline tax could rise or fall in the future, said Deputy Prime Minister Gan Kim Yong. DPM Gan, who visited the US from July 20 to 26, added that he did not get to further discussions on pharmaceutical tariffs being contemplated by the Trump administration. He told the SG60 IPS-SBF Conference on July 29 that these talks did not take place as he did not get the chance to meet Commerce Secretary Howard Lutnick. He did, however, meet other officials, including Treasury Secretary Scott Bessent and Trade Representative Jamieson Greer. They discussed ways to keep up the long and mutually beneficial bilateral economic relationship, as well as potential collaboration in areas like the digital economy. DPM Gan also met business leaders in New York, and congressional leaders handling trade issues in Washington. He also visited an ST Engineering aerostructures factory in Maryland. The US administration was 'not in the mood to discuss any discount to the baseline tariff', DPM Gan said at a dialogue moderated by David Rennie, The Economist's geopolitics editor. 'We also wanted to know whether the baseline tariff will stay at 10 per cent or will it be higher or lower? The answer was non-committal. They are still reviewing the tariff and, in time to come, they will make the appropriate announcement. So we just have to wait and see.' DPM Gan, who is also Minister for Trade and Industry, said he has told US officials that Singapore would be keen to negotiate its baseline tariff rate if the opportunity arises. Pharmaceuticals and semiconductors, which are key exports from Singapore to the US, are currently exempt from baseline tariffs. But US President Donald Trump had earlier in 2025 threatened to end an exemption for pharmaceutical imports, saying tariffs would be imposed 'at a level that you haven't really seen before'. The US is a major market for Singapore-based drugmakers including American multinationals like Pfizer and Johnson & Johnson. DPM Gan said official-level discussions between Singapore and the US Department of Commerce, which commenced before his trip, are still ongoing. 'I can't go into detail because negotiation is ongoing and there's a bit of a confidentiality we need to maintain on both sides,' he said when asked what the US was looking to secure through these talks. He added that the US generally had concerns about what the country experienced during the Covid-19 pandemic, when supplies of critical pharmaceuticals were disrupted. 'They want to make sure that they have a secure supply line of pharmaceuticals. They do want to see whether they can onshore this production, so that they can produce (it) themselves. But they also know that it's not possible to onshore everything, because some of the raw materials are actually (from) outside of America,' he said. 'They do need to think about how they can work with partners, trusted partners, to make sure that their supply chain is secure and reliable. So that is what they are looking for in their partners, including Singapore,' he added. 'I think the administration's focus now is to finish the negotiation of reciprocal tariffs. Then it will start to engage countries on specific sectoral tariffs in pharmaceuticals and semiconductors.' DPM Gan said Singapore has yet to engage the US on the prospect of semiconductor tariffs. However, he added that discussions to preserve the country's access to artificial intelligence equipment and semiconductors are under way. Speaking at the same conference earlier in the day, Prime Minister Lawrence Wong said Singapore's trade and investment relationship with America, even with the tariffs, remains important. 'We would prefer to have zero tariffs of course, but if it is the baseline rate, then we are at the lowest category. We can live with it, and we can still do business and there will still be many opportunities for trade with the US, because whatever is happening in America now, the economy is still resilient, and there is still tremendous innovation happening in American companies, and so there will still be opportunities there,' he said. DPM Gan in his dialogue said the US economy continues to be relatively resilient. He said that based on the feedback from US businessmen he met on his trip, the outlook for the US economy seems cautiously optimistic, adding that Mr Trump's One Big Beautiful Bill, which includes tax cuts and business support measures, may have contributed to this. He said Singapore continues to have a good working relationship with the US. The US was Singapore's second-largest trading partner in 2024, while Singapore was its 16th-largest trading partner. Singapore was also the third-largest Asian investor in the US. More than 250 Singapore companies operate across 45 states, supporting around 350,000 jobs in the US, according to the Republic's Ministry of Trade and Industry. The US also has a longstanding trade surplus and free trade agreement with Singapore. [[nid:720678]] The recent deals between the US and several countries, as well as the European Union economic bloc, are good news, DPM Gan said. 'This gives us a sense that there's good progress in the tariff negotiation. But I also come back with the sense that there remains significant uncertainty. I'm not sure whether the uncertainty has really been eliminated or even reduced,' he added. He cited the lack of clarity on the rules of origin that will be used to determine where products originate from. He also said it is unclear how reciprocal tariffs will be implemented, and how components from different countries and transshipped goods will be assessed. This comes on top of the uncertainty around sectoral tariffs, which are yet to be determined. There is also uncertainty about whether the investments that countries have pledged to the US under tariff deals are new contributions, or money that is currently invested in another country, DPM Gan said. 'For example, the EU has committed to make an investment... over a period of time. Japan has also committed investments into the US. Japan has been a major investor in Singapore. Whether the Japanese investment in Singapore will be diverted to the US is a question that is yet to be seen,' he said. 'There are (also) uncertainties as to how countries will respond to the outcome of the tariff negotiation. Some countries have also committed to purchase more from the US, and they would have been purchasing these products from other countries. Whether now, instead of purchasing from country A, country B, they will now purchase from the US, and therefore exports from these countries to affected countries will be changed,' he added. 'I think these uncertainties (are) second derivative uncertainties. No one is paying much attention yet, because we need to have a tariff settled, then we work out how the secondary impact would be.' Global supply chains will also be restructured if countries move their investments from destinations facing higher US tariffs to those facing lower tariffs, he said. 'The overall global trading system, what we call the rules-based multilateral trading system, that we depend on rules, respecting trade agreements with one another, and not change at will, is something that has been challenged,' DPM Gan said. 'Today, we can agree with one another on a certain tariff, but tomorrow, something happens. We start to change our tariff rate, and that is something that is very uncertain, and that has been seen over the last few months.' [[nid:720154]] This article was first published in The Straits Times . Permission required for reproduction.
CNA
18 minutes ago
- CNA
European fund EQT to take Japan's Fujitec private for $2.7 billion
TOKYO :European investment fund EQT will launch a $2.7 billion tender offer for Fujitec at 5,700 yen per share, the Japanese elevator maker said on Wednesday. Following completion of the tender offer, EQT would own 85 per cent, while Fujitec's founding family would roll over a 15 per cent minority stake, EQT said in a statement. Shares in Fujitec plunged 9.5 per cent to 5,616 yen in early Tokyo trade. ($1 = 148.4400 yen)
